Limited Use Note(s)

Government of Ontario Logo
BUDESONIDE0.25mg/mL Inh Susp
Reason For Use CodeClinical Criteria
For the vast majority of patients, a metered dose inhaler is the preferred therapy. Nebulizer therapy will be reimbursed for patients who are unable to use a metered dose inhaler, including an inhaler with a spacer attachment, or a turbuhaler.
260Children aged 6 years or less;
LU Authorization Period: Indefinite.
261Patients who have a tracheostomy;
LU Authorization Period: Indefinite.
262Patients with cystic fibrosis in whom nebulizer therapy is indicated;
LU Authorization Period: Indefinite.
263Patients with severe mental or physical disabilities;
LU Authorization Period: Indefinite.
264Patients who have previously used nebulizer therapy within the last 12 month period.
LU Authorization Period: Indefinite.